The Impact of Treatment-Free Remission of Tasigna® for Cml Patients in China – A Cost Effectiveness Analysis
Abstract
Authors
S Chen JW Xuan Y Zhang H Zhu J Luo J Tan C Liu M Qiu S Qu T Xiong
S Chen JW Xuan Y Zhang H Zhu J Luo J Tan C Liu M Qiu S Qu T Xiong
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now